Feb. 10, 2012
/PRNewswire-Asia/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the research, development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced that the Company is invited to attend the 32nd Cowen's Healthcare Conference which is to take place from
Monday March 5th
Wednesday March 7th
at the Boston Marriott Copley Place Hotel.
Headquartered at Chengdu,
, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, mTCM, branded generics and API. TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of
. TPI's pipeline targets various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.
For more information about TPI, please visit:
Safe Harbor Statement
The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.
For more information, please visit:
, or email:
Tel: +86-28-8551-6696 (
) +86-134-3655-0011 (
)Address:Tianyin Pharmaceutical Inc.23rd Floor, Unionsun Yangkuo PlazaNo. 2, Block 3, South Renmin Road
SOURCE Tianyin Pharmaceutical Co., Inc.